NDA 17-037/S-158
Page 21
1 mL DOSETTE vials packaged in 25s (NDC 0641-0392-25)
2 mL DOSETTE vials packaged in 25s (NDC 0641-0393-25)
10 mL Multiple Dose vials packaged in 25s (NDC 0641-2438-45)
30 mL Multiple Dose vials packaged in 25s (NDC 0641-2442-45)
100 USP units/mL
1 mL DOSETTE vials packaged in 25s (NDC 0641-0389-25)
2 mL DOSETTE vials packaged in 25s (NDC 0641-0387-25)
10 mL Multiple Dose vials packaged in 25s (NDC 0641-2436-45)
30 mL Multiple Dose vials packaged in 25s (NDC 0641-2443-45)
Storage
Store at 20
°
-25°
C (68°
-77°
F) [
see USP Controlled Room Temperature]
.
REFERENCES
1. Tahata T, Shigehito M, Kusuhara K, Ueda Y, et al. Delayed-Onset of Heparin Induced Thrombocytopenia –
A Case Report –
J Jpn Assn Torca Surg.1992;40(3):110-111.
2. Warkentin T, Kelton J. Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis.
Annals of
Internal Medicine. 2001;135:502-506.
3. Rice L, Attisha W, Drexler A, Francis J. Delayed-Onset Heparin Induced Thrombocytopenia.
Annals of
Internal Medicine, 2002;136:210-215.
4. Dieck J., C.
Rizo-Patron, et al. (1990). “A New Manifestation and Treatment Alternative for Heparin-
Induced Thrombosis.” Chest 98(1524-26).
5. Smythe M, Stephens J, Mattson. Delayed-Onset Heparin Induced Thrombocytopenia.
Annals of Emergency
Medicine, 2005;45(4):417-419.
6. Divgi A. (Reprint), Thumma S., Hari P., Friedman K., Delayed Onset Heparin-Induced Thrombocytopenia
(HIT) Presenting After Undocumented Drug Exposure as Post-Angiography Pulmonary Embolism.
Blood.
2003;102(11):127b.
Hep-Lock, Baxter and Dosette are registered trademarks of Baxter International, Inc., or its
subsidiaries.
Manufactured by
Dostları ilə paylaş: